Polymorph of a pharmaceutical

Details Polymorph of a pharmaceutical Polymorph of a pharmaceutical

2005-05-17

2005-05-17

Stockton, Laura L. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

06894171

ABSTRACT:
A new crystalline polymorph of ritonavir and methods for its use and preparation are disclosed.

REFERENCES:
patent: 5484801 (1996-01-01), Al-Razzak et al.
patent: 5541206 (1996-07-01), Kemp et al.
patent: 5559158 (1996-09-01), Al-Razzak et al.
patent: 5567823 (1996-10-01), Tien et al.
patent: 5648497 (1997-07-01), Kempf et al.
patent: 5725878 (1998-03-01), Al-Razzak et al.
patent: 9701349 (1997-01-01), None
patent: 9822106 (1997-11-01), None
Bauer, J., et al., “Ritonavir: An Extraordinary Example of Conformational Polymorphism”,Pharmaceutical Research,18(6):859-866 (2001).
Byrn, S. R., “Solid-State Chemistry of Drugs”,Academic Press,3-27, 79-148 (1982).
Byrn, S., et al., “Pharmaceutical Solids: A Strategic Approach to regulatory Considerations”,Pharmacetical Research,12(7):945-954 (1995).
Dunitz, J. D. & Bernstein, J., “Disappearing Polymorphs”,Acc. Chem. Res.,28:193-200 (1995).
Byrn, S.R., et al., “Solid-State Pharmaceutical Chemistry”,Chem. Mater.,6, 1148-1158 (1994).

Affiliated with

Also associated with

Rating

Polymorph of a pharmaceutical does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polymorph of a pharmaceutical, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorph of a pharmaceutical will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3424173